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Abstract
Introduction: Galanin (Gal) may be involved as the neuromodulator of different processes in the central nervous system in the regulation 
of neurohypophysial function. The aim of the present study was to examine the influence of Gal on oxytocin (OT) release in vitro: an acute 
or prolonged osmotic stimulus was used as the stimulatory agent.  
Material and methods: Experiments were carried out on three-month old male rats which acted as donors of isolated rat hypothalamus 
(Hth), neurohypophysis (NH) or hypothalamo-neurohypophysial explants (Hth-NH). The effect of Gal on OT secretion was studied under 
conditions of non-osmotic (i.e. K+-evoked) (series 1), direct osmotic (i.e. Na+-evoked) (series 2) or indirect osmotic stimulation (series 3; 
neural tissues were obtained from animals drinking 2% NaCl). OT content was determined by radioimmunoassay.
Results: Galanin added into incubative media caused the inhibition of basal OT release from NH and Hth-NH explants prepared from 
euhydrated rats but stimulated basal and K+-stimulated OT release from the Hth tissue. Gal did not exert any influence on Na+-evoked 
OT secretion. We observed increased basal OT secretion from NH and K+-evoked respective OT release from Hth and Hth-NH explants 
taken from osmotically challenged rats under the influence of Gal.
Conclusions: Present experiments in vitro show that: 
1. Galanin plays the role of an inhibitory neuromodulator of OT release from the neurohypophysis; its effect is opposite at the hypotha-
lamic level. 
2. Galanin acts as the stimulatory neuromodulator of OT release in response to prolonged osmotic stimulus; an acute osmotic stimulus 
blocks OT-ergic neurons susceptible to Gal. (Endokrynol Pol 2013; 64 (2): 139–148)
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Streszczenie
Wstęp: Galanina (Gal) jako neuromodulator różnych procesów w ośrodkowym układzie nerwowym może być zaangażowana w regulacji 
funkcji części nerwowej przysadki. Celem obecnych doświadczeń było zbadanie wpływu Gal na uwalnianie oksytocyny (OT) in vitro: 
zastosowano ostry lub przewlekły bodziec osmotyczny jako czynnik pobudzający.
Materiał i metody: Badania zostały przeprowadzone na 3-miesięcznych szczurach samcach, od których pobierano podwzgórze (Hth), 
część nerwową przysadki (NH) lub układ podwzgórzowo-przysadkowy (Hth-NH). Wpływ Gal na uwalnianie OT był badany w wa-
runkach braku pobudzenia osmotycznego — stymulacja jonami K+ (seria 1), podczas ostrego pobudzenia osmotycznego wywołanego 
jonami Na+ zawartymi w płynie inkubacyjnym (seria 2) lub w trakcie stymulacji osmotycznej o charakterze pośrednim, kiedy tkanki 
nerwowe pobierano od zwierząt otrzymujących do picia 2% roztwór NaCl (stan przewodnienia hipertonicznego) (seria 3). Zawartość 
OT oznaczano metodą radioimmunologiczną.
Wyniki. Seria 1: Galanina obecna w medium inkubacyjnym hamowała podstawowe uwalnianie OT z NH i układu Hth-NH, natomiast 
pobudzała podstawowe i stymulowane jonami K+ uwalnianie OT z Hth. Seria 2: Gal nie wywierała żadnego wpływu na sekrecję OT in-
dukowaną jonami Na+ zawartymi w płynie inkubacyjnym. Seria 3: Gal była przyczyną wzrostu podstawowego uwalniania OT z NH oraz 
stymulowanego jonami potasu uwalniania OT z Hth oraz układu Hth-NH pobranych od szczurów w stanie przewodnienia hipertonicznego.
Wnioski. Na podstawie obecnych badań in vitro można przyjąć, że: 
1. Gal pełni funkcję neuromodulatora hamującego uwalnianie OT z części nerwowej przysadki, natomiast wywiera efekt przeciwny na 
poziomie podwzgórza. 
2. Gal działa jako neuromodulator pobudzający uwalnianie OT w odpowiedzi na stan przewlekłego pobudzenia osmotycznego; ostry 
bodziec osmotyczny blokuje wrażliwość neuronów OT-ergicznych na działanie galaniny.  (Endokrynol Pol 2013; 64 (2): 139–148)
Słowa kluczowe: galanina, oksytocyna, bodziec osmotyczny, metodyka in vitro 
Part of this paper was presented at the XLIV Annual Meeting of the Polish Biochemical Society, Łódź September 16th – 19th, 2009; Acta 
Biochimica Polonica 2009, vol. 56, suppl. 3, Abstracts, p. 143.
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Introduction
In a similar way to vasopressin (AVP), oxytocin (OT) is 
produced by the neurons of the supraoptic (SON) and 
paraventricular (PVN) nuclei of the hypothalamus, and 
after its transport towards the neurohypophysis, is re-
leased into the blood. OT is involved in the regulation of 
different physiological processes in females and males, 
such as the function of the uterus and mammary glands, 
cardiovascular regulation and neuroendocrine func-
tion [1]. Moreover, it has been suggested that OT plays 
a role as a nonhypertensive natriuretic agent. OT has 
been demonstrated to affect the process of natriuresis 
in water-deprived rats [2]. The states of hypernatraemia 
and plasma hyperosmolality activate magnocellular OT-
ergic neurons [3, 4], resulting in increased OT release 
into the blood [5, 6]. A prolonged salt-loading state 
has been found to significantly increase OT mRNA 
levels [7]. In addition, OT content of the hypothalamic 
SON, PVN and the neurohypophysis decreases with 
increased OT plasma level [6, 8, 9]. Therefore, it has 
been postulated that a positive feedback mechanism 
may exist between OT secretion and plasma sodium 
concentration [10, 11]. 
Numerous neuromediators/neuromodulators are 
involved in regulating the activity of the hypothalamo-
neurohypophysial system [12–15]. Many studies have 
emphasised the role of galanin (Gal) in the modulation 
of the release of neurohypophysial hormones [16–20]. 
Gal is widely distributed in the rat central nervous sys-
tem (CNS) [21–23] with the highest expression in the 
hypothalamus, amygdaloid complex, brainstem and 
spinal cord as well as in the neurohypophysis [24, 25]. 
In the rat hypothalamus, neurons containing Gal have 
been observed mainly in the preoptic area, supraoptic 
nuclei and paraventricular nuclei [in magnocellular 
(mPVN) as well as parvocellular (pPVN) subdivision 
of  PVN], in arcuate nucleus and median eminence 
[21, 26]. Gal coexists with AVP or OT in the neurons 
of SON and PVN [27, 28]. SON and PVN appear to 
have a high density of binding sites for all three types 
of Gal [29, 30]. Gal receptor type 1 (GalR1) is present 
mainly in the CNS, whereas large amounts of GalR2 
and GalR3 are expressed at low levels in both the CNS 
and peripheral tissues [31].
It has been shown that Gal may exert a significant 
effect on the function of the hypothalamo-neuro-
hypophysial (Hth-NH) system in different states of 
water-electrolyte balance. Some authors [16, 17] have 
noted that centrally-infused Gal diminishes hypertonic 
saline-induced AVP as well as OT secretion. Some of 
our earlier studies confirm the participation of Gal 
in OT release in vivo from the neurohypophysis in 
dehydrated, as well as osmotically challenged, rats [6, 
32]. It was observed that intracerebroventricular (icv) 
injections of Gal into rats deprived of water distinctly 
inhibited OT release from the Hth-NH system [32]. Gal 
has been seen to induce similar effects after icv injec-
tions into salt-loaded rats i.e. the OT content of the 
hypothalamus and neurohypophysis rises and its level 
in the plasma decreases [6]. Our latest in vitro study [33] 
demonstrated the distinct inhibitory influence of Gal on 
basal OT release from the neurohypophysis, as well as 
hypothalamo-neurohypophysial explants taken from 
rats in a state of equilibrated water-electrolyte balance. 
Gal did not exert any effect on K+-evoked OT release 
from either NH or Hth-NH explants. However, both 
basal and K+-stimulated types of OT release from the 
hypothalamus were distinctly intensified under the 
influence of Gal [33]. 
Therefore, the aim of the present in vitro study 
was to investigate the possible influence of Gal on OT 
release from the hypothalamus, neurohypophysis or 
hypothalamo-neurohypophysial system in states of 
direct or indirect hyperosmotic stimulation. 
Material and methods
Subjects
One hundred and forty three male three-month-old 
Wistar rats weighing 250–290 g were used in all in vitro 
experiments. They were housed four animals per cage 
under conditions of constant room temperature (20–22o C), 
humidity and lighting: a 12h/12h light/dark cycle, with 
lights on from 6 a.m. The animals received standard pel-
leted food and tap water ad libitum; however, in the third 
series of experiments, 2% NaCl solution was provided 
instead of tap water for eight days before decapitation. 
The experimental procedures were performed with the 
consent of the Lodz Local Commission of Ethics. 
Drugs
Galanin [Gal] was purchased from Bachem [Galanin 
(rat) lot 0560209]. OT, for standard curve preparation 
as well for iodination with 125I, was obtained from Pen-
insula Laboratories Europe Ltd.
Procedures
On the day of the experiment, the animals were de-
capitated between 9.00 and 10.00 a.m. The procedure 
of decapitation was carried out very quickly with the 
use of a guillotine. Each rat was decapitated in the 
laboratory room separately from the other animals. The 
brain and the pituitary with intact pituitary stalk were 
carefully removed from the skull: the disruption of the 
cranial bones has been started from the superior area. 
Three types of neuronal tissue were then prepared: (i) 
a block of tissue containing the hypothalamus (Hth), 
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or (ii) the neurohypophysis (NH), or (iii) the intact 
hypothalamo-neurohypophysial system (Hth-NH) [34]. 
The hypothalamus and the neurohypophysis were 
taken from the brain of the same animal, but other rats 
were used for isolation of the hypothalamo-neurohy-
pophysial system. The blocks of hypothalamic tissue 
were dissected as follows: rostral limit — frontal plane 
situated about 1.0 mm anterior to the anterior margin 
of the optic chiasm; caudal limit — frontal plane just 
behind the mammilary bodies; lateral limits — sagittal 
planes passing, on both sides, just through the hypo-
thalamic fissures [6, 35]. The depth of dissection was 
approximately 2.5–3.0 mm from the base of the brain. 
A single explant was approximately 5 mm wide and 
weighed approximately 35-40 mg. The total dissec-
tion time was about 3 min from the decapitation. This 
hypothalamo-neurohypophysial explant (Hth-NH) 
contained the suprachiasmatic nucleus (SCN) as well 
as the SON and PVN hypothalamic nuclei with intact 
axonal projections to the neurohypophysis: the anterior 
lobe of the pituitary having been excised [6, 36]. The 
hypothalamic tissue was divided into two parts before 
incubation [37].
Each type of isolated neural tissue was placed im-
mediately in a polypropylene tube with 1 ml of Krebs-
Ringer fluid [termed normal KRF (nKRF)] containing: 
120 mM NaCl, 5 mM KCl, 2.6 mM CaCl2, 1.2 mM 
KH2PO4, 0.7 mM MgSO4, 22.5 mM NaHCO3, 10 mM 
glucose, 1.0 g/L bovine serum albumin and 0.1 g/L ascor-
bic acid (pH = 7.37–7.46; osmolality 280–290 mOsm/Kg 
H2O). Tubes were placed in a water bath at 37
oC and 
constantly gassed with carbogen (a mixture of 95% O2 
and 5% CO2). At the beginning of the experiment, the 
appropriate type of prepared tissue was equilibrated 
in nKRF which was then aspirated twice and replaced 
with 1 ml of fresh medium. After 80 minutes of such 
preincubation, the nKRF was discarded and the tissues 
were incubated for 20 minutes in either 1 ml of nKRF 
alone, or containing the appropriate concentrations of 
galanin.
In the first series of experiments, the effect of Gal 
on non-osmotically stimulated (i.e. potassium-evoked) 
OT release was studied using neural tissues isolated 
from euhydrated animals. The appropriate type of 
prepared tissue (Hth, NH, Hth-NH) isolated from rats 
drinking tap water ad libitum (euhydrated animals) 
was incubated successively in: (1) Normal KRF (B1); 
(2) Modified KRF containing the excess of potassium 
ions (56 mM; NaCl concentration in the medium was 
appropriately reduced to maintain the osmolality) (S1); 
(3) The incubation fluid as (1) alone or with Gal at the 
concentrations of 10-10 or 10-8 M (B2); and finally (4) The 
KRF as (2) alone, or with Gal in the same concentrations 
as (3) (S2). Incubation in each medium proceeded for 
20 min. In between incubation periods (2) and (3), the 
tissues were washed in the normal medium and these 
samples were discarded.
In the second series of experiments, the effect of 
Gal on basal and Na+–stimulated (i.e. acute osmotic 
stimulation) OT release was studied. The appropriate 
type of prepared tissue (Hth, NH, Hth-NH) isolated 
from rats drinking tap water ad libitum (euhydrated 
animals) were incubated successively in (1) normal KRF 
(B1); (2) modified KRF containing an excess of sodium 
chloride (medium osmolality in the range of 320–330 
mOsm/Kg H2O) (S1); (3) the incubation fluid as (1) alone 
or with Gal at concentrations of 10-10 or 10-8 M (B2); and 
finally (4) the KRF as (2) alone or with Gal in the same 
concentrations as (3) (S2). 
In the third series of experiments, the effect of Gal 
on basal and K+-evoked OT release from the neural 
tissues obtained from osmotically challenged animals 
was studied: rats drinking 2% NaCl for eight days. The 
experimental protocol was the same as in the first series.
In euhydrated rats (series 1) as well as in salt-loaded 
rats (series 3), the plasma osmolality and haematocrit 
index were estimated. Plasma osmolality was meas-
ured in duplicate by freezing point depression using 
a semimicroosmometer (Knauer & Co GMBH, Berlin, 
Germany). The body weight of rats from series 3 was 
determined at the beginning and at the end of the 
eight-day period of salt loading. The initial and final 
body mass of the rats in the first series of experiments 
was similarly estimated before and after eight days of 
maintenance of animals under standard conditions. 
After each incubation, the media were aspirated and 
samples immediately frozen and stored at –25oC until 
OT estimation by radioimmunoassay.
Radioimmunoassay (RIA)
The concentrations of OT in the medium samples 
were determined by double-antibody specific RIA. 
Anti-OT antibodies were raised in the Department of 
Experimental Physiology, Chair of Experimental and 
Clinical Physiology, Medical University of Lodz. A more 
detailed description of antibodies has been given earlier 
by Cisowska-Maciejewska and Ciosek [6]. For iodina-
tion with 125I and for standard curve preparation, the 
chloramine-T method using standard OT (Oxytocin 
synth.) was used. The lower limit of detection for the 
assay was 1.25 pg OT/100 µL; the intra-assay coefficient 
of variation for OT was less than 5% (all samples within 
each experimental series were tested in the same RIA 
to avoid inter-assay variability).
Statistical evaluation of the results
OT release into incubative media was estimated by 
calculating the ratios between the two incubation peri-
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ods B2/B1 (basal release) and S2/S1 (stimulated release) 
for each kind of incubated tissue: the hypothalamus, 
neurohypophysis or hypothalamo-neurohypophysial 
system. The final results of OT secretion were expressed 
as a percentage of the control value. In each experimen-
tal group, the results were calculated and expressed 
as means ± S.E.M. Significance of the differences 
between the means was determined by the use of the 
Kruskal-Wallis analysis of variance (ANOVA) followed 
by the Mann-Whitney ‘U’ test (the comparison of two 
means); p < 0.05 was considered as the minimal level 
of significance.
Results
Stimulation with potassium (incubation phase S1 
of series 1 and 3) or sodium (osmotic stimulus) ions 
(incubation phase S1 of series 2) caused augmented 
OT release (p < 0.001) from the isolated Hth, NH and 
Hth-NH explants (Fig. 1).
The values for body weight, plasma osmolality and 
haematocrit index in euhydrated and salt-loaded rats are 
shown in Table I. The body weight of rats drinking 2% 
saline for eight days (series 3) was reduced by 14% and 
their plasma osmolality and haematocrit were markedly 
increased (about 17% and 11%, respectively) compared 
to control values obtained from euhydrated rats (series 1).
Series 1. Incubation of neural tissues isolated 
from intact (control) rats (Fig. 2A, B, C) 
Gal added into the basal medium at concentrations of 10-
10 and 10-8 M diminished OT secretion from both the NH 
and Hth-NH explants (Fig. 2B and C: p < 0.02). However, 
when applied at a concentration of 10-10 M, Gal stimulated 
basal OT release during incubation of the hypothalamic 
tissue (Fig. 2A: p < 0.05). Although, under K+-stimulation 
OT release from NH and Hth-NH complex did not change 
under the influence of either tested Gal concentration (Fig. 
2B and C), OT secretion from the hypothalamus was seen 
to rise (Fig. 2A: p < 0.02 and p < 0.05). 
Figure 1. Comparison of the basal (period B1) and stimulated (period S1) oxytocin (OT) release from isolated rat Hth, NH or Hth-NH 
explants as estimated from all experiments of each series (mean ± SEM); *p < 0.001
Rycina 1. Porównanie podstawowego (okres B1) i stymulowanego (okres S1) uwalniania oksytocyny (OT) z wyizolowanych Hth, NH 
lub układów Hth-NH oszacowane na podstawie wszystkich doświadczeń każdej serii (mean ± SEM); *p < 0.001
Table I. Body weight, plasma osmolality and haematocrit in rats drinking tap water or 2% saline
Tabela I. Masa ciała, osmolalność osocza i wskaźnik hematokrytowy u szczurów otrzymujących do picia czystą wodę lub 
2-procentowy roztwór soli
Rats Initial body weight [g] Final body weight [g] Haematocrit (%) Plasma osmolality  
[mOsmol/kg H2O]
Euhydrated 272 ± 2 288 ± 3 46 ± 1 281 ± 2
Salt-loaded 272 ± 3 233 ± 3 51 ± 1 329 ± 2
Statistical significance NS p < 0.001 p < 0.001 p < 0.001
Values are mean ± S.E.M.
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Series 2. Incubation of neural tissues exposed to 
direct osmotic stimulation (i.e. evoked by Na+ ions 
added into the medium) (Fig. 3A, B, C) 
During the basal period of the incubation in Krebs-
Ringer fluid, Gal action was similar to that observed 
in series 1, OT secretion was inhibited from NH and 
Hth-NH explants at both Gal concentrations, while 
it was raised from Hth tissue at 10-10 M Gal (Fig. 3A: 
p < 0.05; Fig. 3B and C: p < 0.02 and p < 0.05). When 
neural tissues were incubated in the medium enriched 
in Na+ ions (acute osmotic stimulus), Gal did not exert 
a significant influence on OT secretion (Fig. 3A, B and C).
Series 3. Incubation of neural tissues isolated 
from osmotically challenged animals (Fig. 4A, B, C)
Gal at a concentration of 10-10 M markedly increased 
basal OT secretion from NH (Fig. 4B: p < 0.02) while 
10-10 and 10-8 M Gal also increased potassium-stimulated 
OT release from Hth and Hth-NH explants (Fig. 4A and 
C: p < 0.01, p < 0.02 and p < 0.05). Gal did not modify 
potassium-evoked OT secretion from the NH (Fig. 4B).
Discussion
These results demonstrate the distinct role played 
by Gal in the release of OT from the hypothalamo-
neurohypophysial system in vitro. These results clearly 
show that Gal’s action depends on the different states 
of water-electrolyte balance in the experimental ani-
mals, as well as on the electrolyte composition of the 
incubation fluid. 
In fact, the release of the neurohormones of poste-
rior lobe of the pituitary is closely connected with the 
actual state of water-electrolyte homeostasis [6, 38]. Both 
AVP-ergic and OT-ergic neuron activities, as well as AVP 
and OT mRNA expression, increase significantly in the 
rat hypothalamus in response to acute or chronic os-
motic stimuli such as salt-loading or water deprivation 
[39, 40]. The respective information is sent to some brain 
structures involved in osmoregulatory mechanisms re-
lated to AVP-ergic as well as OT-ergic neurons excitation 
[41–43]. Therefore, the number of Fos immunoreactive 
neurons increases in such hypothalamic osmosensitive 
structures as the medial preoptic area (MnPO), orga-
num vasculosum of the lamina terminalis (OVLT), PVN 
and SON after icv osmotic stimulations [43]. It is worth 
noting that OT secretion from the posterior pituitary in 
response to salt-loading is even greater than AVP release 
[44–46]. In the present study, two modes of OT-ergic 
neuron stimulation have been applied, i.e. non-osmotic 
(potassium-evoked) and osmotic stimuli (sodium ions-
evoked). Osmotic stimulation of OT-ergic neurons may 
have a direct character, brought about by an excess 
of sodium ions added into the incubative fluid, or an 
Figure 2A. The effect of galanin (Gal) on the basal and K+-evoked OT 
release from the hypothalamus obtained from euhydrated rats (series 
1). Each bar represents mean ± SEM and figures in bars indicate the 
number of samples per group. B. The effect of galanin (Gal) on the 
basal and K+-evoked OT release from the neurohypophysis obtained 
from euhydrated rats (series 1). Each bar represents mean ± SEM 
and figures in bars indicate the number of samples per group. C. The 
effect of galanin (Gal) on the basal and K+-evoked OT release from the 
hypothalamo-neurohypophysial explants obtained from euhydrated 
rats (series 1). Each bar represents mean ± SEM and figures in bars 
indicate the number of samples per group 
Rycina 2A. Wpływ galaniny (Gal) na podstawowe oraz 
indukowane jonami K+ uwalnianie OT z podwzgórza izolowanego 
od szczurów w stanie równowagi wodno-elektrolitowej (seria 
1). Wyniki przedstawiają średnią ± SEM; dane w kolumnach 
określają liczbę próbek w grupie. B. Wpływ galaniny (Gal) 
na podstawowe oraz indukowane jonami K+ uwalnianie OT 
z części nerwowej przysadki izolowanej od szczurów w stanie 
równowagi wodno-elektrolitowej (seria 1). Wyniki przedstawiają 
średnią ± SEM; dane w kolumnach określają liczbę próbek 
w grupie. C. Wpływ galaniny (Gal) na podstawowe oraz 
indukowane jonami K+ uwalnianie OT z układu podwzgórzowo-
przysadkowego izolowanego od szczurów w stanie równowagi 
wodno-elektrolitowej (seria 1). Wyniki przedstawiają średnią ± 
SEM; dane w kolumnach określają liczbę próbek w grupie
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Figure 3A. The effect of galanin (Gal) on the basal and Na+-evoked 
OT release from the hypothalamus obtained from euhydrated 
rats (series 2). Each bar represents mean ± SEM and figures 
in bars indicate the number of samples per group. B. The effect 
of galanin (Gal) on the basal and Na+-evoked OT release from 
the neurohypophysis obtained from euhydrated rats (series 2). 
Each bar represents mean ± SEM and figures in bars indicate 
the number of samples per group. C. The effect of galanin (Gal) 
on the basal and Na+-evoked OT release from the hypothalamo-
neurohypophysial explants obtained from euhydrated rats (series 
2). Each bar represents mean ± SEM and figures in bars indicate 
the number of samples per group
Rycina 3A. Wpływ galaniny (Gal) na podstawowe oraz 
indukowane jonami Na+ uwalnianie OT z podwzgórza izolowanego 
od szczurów w stanie równowagi wodno-elektrolitowej (seria 
2). Wyniki przedstawiają średnią ± SEM; dane w kolumnach 
określają liczbę próbek w grupie. B. Wpływ galaniny (Gal) na 
podstawowe oraz indukowane jonami Na+ uwalnianie OT z 
części nerwowej przysadki izolowanej od szczurów w stanie 
równowagi wodno-elektrolitowej (seria 2). Wyniki przedstawiają 
średnią ± SEM; dane w kolumnach określają liczbę próbek 
w grupie. C. Wpływ galaniny (Gal) na podstawowe oraz 
indukowane jonami Na+ uwalnianie OT z układu podwzgórzowo-
przysadkowego izolowanego od szczurów w stanie równowagi 
wodno-elektrolitowej (seria 2). Wyniki przedstawiają średnią ± 
SEM; dane w kolumnach określają liczbę próbek w grupie
Figure 4A. The effect of galanin (Gal) on the basal and K+-evoked 
OT release from the hypothalamus obtained from rats drinking 2% 
saline for eight days (series 3). Each bar represents mean ± SEM 
and figures in bars indicate the number of samples per group. B. The 
effect of galanin (Gal) on the basal and K+-evoked OT release from 
the neurohypophysis obtained from rats drinking 2% saline for eight 
days (series 3). Each bar represents mean ± SEM and figures in bars 
indicate the number of samples per group. C. The effect of galanin 
(Gal) on the basal and K+-evoked OT release from the hypothalamo-
neurohypophysial explants obtained from rats drinking 2% saline for 
eight days (series 3). Each bar represents mean ± SEM and figures 
in bars indicate the number of samples per group
Rycina 4A. Wpływ galaniny (Gal) na podstawowe oraz 
indukowane jonami K+ uwalnianie OT z podwzgórza izolowanego 
od szczurów otrzymujących do picia 2% roztwór soli przez 8 dni 
(seria 3). Wyniki przedstawiają średnią ± SEM; dane w kolumnach 
określają liczbę próbek w grupie. B. Wpływ galaniny (Gal) na 
podstawowe oraz indukowane jonami K+ uwalnianie OT z części 
nerwowej przysadki izolowanej od szczurów otrzymujących do 
picia 2% roztwór soli przez 8 dni  (seria 3). Wyniki przedstawiają 
średnią ± SEM; dane w kolumnach określają liczbę próbek w 
grupie. C. Wpływ galaniny (Gal) na podstawowe oraz indukowane 
jonami K+ uwalnianie OT z układu podwzgórzowo-przysadkowego 
izolowanego od szczurów otrzymujących do picia 2% roztwór soli 
przez 8 dni  (seria 3). Wyniki przedstawiają średnią ± SEM; dane 
w kolumnach określają liczbę próbek w grupie
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indirect character, connected with afferent impulsation 
originating from systemic and central osmoreceptors in 
salt-loading rats [5, 41, 47, 48]. 
The addition of sodium ions to incubative media 
causes direct osmotic excitation of magnocellular neu-
rons. This leads to membrane depolarisation of AVP-
ergic and OT-ergic neurons, thus increasing their firing 
rate and the release of both neurohormones release [41]. 
Under in vitro conditions, it is mainly the perikarya of 
these neurons which react to direct osmotic stimulation 
[49], whereas potassium-evoked depolarisation excites 
the cell bodies of these neurons and the terminals of 
their axons in the neurohypophysis. 
A prepared neurohypophysis incubated in vitro is 
without doubt the classic and most convenient model 
for studying AVP-ergic and OT-ergic neuron activity, 
and has been used for many years [36, 50]. These tis-
sues maintain the ability to modulate their AVP and 
OT secretion in response to stimuli for at least a few 
hours [12, 51]. It has been assumed that in this incuba-
tion model, the changes in neurohormone release are 
due to the direct action of various biologically active 
compounds on neurosecretory endings in the posterior 
lobe of the pituitary. 
For the in vitro study of AVP and OT release, the 
whole isolated hypothalamo-neurohypophysial sys-
tem is also used [51, 52]. This model enables the neural 
consecutiveness of the hypothalamo-neurohypophysial 
tracts to be maintained, which ensures the integrality of 
the processes taking place there. It has been assumed 
that most nervous fibres ending by the synapses in the 
AVP-ergic and OT-ergic bodies within the paraven-
tricular and supraoptic nuclei of the hypothalamus are 
intact. In such a prepared specimen, the permanence of 
neural hypothalamo-neurohypophysial tracts is main-
tained, as are most processes related to the biosynthesis, 
transport, and secretion of AVP and OT [49]. 
Based on earlier reports [53], a prepared block of 
neural tissue including the hypothalamus and the 
part of the thalamus which contained the neurons of 
paraventricular and supraoptic nuclei as well as supra-
chiasmatic nuclei, was used in the present study. This 
approach allows the hypothalamic AVP-ergic and OT-
ergic neurons incubated in the medium to be exposed 
directly to the tested compounds. The observed changes 
of AVP and OT secretion into the incubated fluid allow 
the biosynthetic rate of both neurohormones, as well 
as their release into the surrounding tissues, to be esti-
mated at the hypothalamic level.  
Hypothalamo-neurohypophysial system activity 
may be modulated by the participation of many dif-
ferent neuromodulators/neuromediators in the cen-
tral nervous system (CNS), one of which is galanin. 
Gal-like neurons, Gal receptors (GalRs) as well as Gal 
mRNA have been observed in the hypothalamus, me-
dian eminence and posterior lobe of the pituitary [21]. 
Some authors [19, 30] have noted the presence of the 
receptors for Gal (GalR1, GalR2, GalR3) in the MnPO, 
PVN and SON. GalR1 mRNA has been shown to exist 
in high amounts in SON, mPVN and pPVN by in situ 
hybridisation studies [19, 21]. GalR2 mRNA has been 
detected in the PVN but not in SON [21]. Gal-ergic neu-
rons from different areas of the brain project to areas of 
the hypothalamus, including SON and PVN, as well as 
the anteroventral region of the third ventricle (AV3V) 
[26, 42]. Rich Gal-ergic projection innervates AVP-ergic 
and OT-ergic neurons in hypothalamic magnocellular 
nuclei. High Gal immunoreactivity has been observed 
in the perinuclear area of magnocellular neurons and 
in their dendrites [21, 54–56]. Colocalisation of Gal with 
OT is possible, and has been demonstrated in such 
experimental conditions as treatment with colchicin, 
an alkaloid inhibiting neurohormonal axonal transport 
[57, 58] or hypophysectomy [8, 59]. High expression of 
Gal mRNA is found in the PVN and SON in the pres-
ence of OT [8, 60].
Our earlier in vivo and in vitro studies demonstrate 
the possible influence of Gal on OT and/or AVP release. 
AVP release was found to be inhibited when Gal was in-
jected centrally to hypertonic saline-treated rats [16]. No 
effect of icv injection of Gal on OT mRNA content has 
been found in dehydrated rats [61]. On the other hand, 
although Björkstrand et al. [17] observed a significant 
decrease of OT plasma level in rats after icv injection of 
Gal, this has yet to be confirmed by other studies [62]. 
Our team observed icv injections of galanin to have an 
inhibitory influence on OT secretion in dehydrated 
animals, as well as those drinking hypertonic saline 
[6, 32]. Our previous studies also note that Gal has 
an inhibitory effect on basal OT release from NH and 
Hth-NH explants in vitro, when different concentrations 
are added into incubative media [33]. Our most recent 
study demonstrates that Gal added into incubative 
media inhibits basal (but not potassium-stimulated) 
AVP release from the Hth-NH complex of osmotically 
challenged animals [34]. 
The present results of control incubation (series 1) 
indicate that Gal may play a neuromodulatory role in 
the secretion of OT from the hypothalamo-neurohy-
pophysial system under in vitro conditions, but this 
effect is undirected. The inhibitory effect of Gal on basal 
OT release from incubated NH and Hth-NH explants 
confirms the data presented above [33]. These results 
are also in agreement with earlier in vitro experiments 
by Gálfi et al. [63] who observed concentrations of Gal 
ranging from 10-6 to 10-9 M to have an inhibitory influ-
ence on basal OT release from the 13–14 day neurohy-
pophysial cell cultures.
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However, in the present study, Gal was seen to in-
tensify OT secretion from the hypothalamic tissue both 
in basal and K+-evoked conditions, which corresponds 
with the results obtained in our earlier studies [33]. 
Moreover, it is worthy of note that only the lowermost 
Gal concentration (10–10 M) exerted such an effect: 
higher concentrations displayed no significant influ-
ence on OT release from incubated hypothalamic tissue. 
On the other hand, the contradictory nature of 
Gal on OT secretion confirms our previous observa-
tions: its stimulatory influence on Hth contrasts with 
its inhibitory effect on other incubated tissues (NH or 
Hth-NH complex) [33]. It cannot be excluded that the 
cell bodies of OT-ergic neurons can respond to Gal in 
a different manner to the axonal endings of these neu-
rons in the neurohypophysis. Moreover, there is the 
high probability that Gal can inhibit the infundibular 
transport of both neurohormones from the hypothala-
mus towards the neurohypophysis. Such action of Gal 
may lead to decreased OT release from the posterior 
lobe of the pituitary as well as from the hypothalamo-
neurohypophysial system.
In the second series of tests, acute osmotic stimulus 
induced by an excess of sodium ions present in the 
medium was seen to block the influence of Gal on OT 
release. No change in Na+-stimulated OT release was 
found, however, basal OT secretion under Gal influ-
ence had the same character as in series 1. This effect 
is difficult to interpret, but it could be caused by the 
disturbed sensibility of Gal receptors to this peptide 
during acute osmotic stimulation. 
The third series of tests in the present study used 
salt-loaded rats as the donor animals of neural tissues for 
in vitro incubation. It is known that hyperosmolality of 
extracellular fluids, such as plasma and CSF, is the main 
stimulus for AVP and OT release from the neurohypo-
physis into the blood. Experimental animals drinking 
a hypertonic solution of sodium chloride for a few days 
show a prompt increase of plasma osmolality, as well 
as AVP and OT release [6, 64, 65]. In the present in vitro 
experiments, OT plasma level was not determined in 
salt-loading rats after decapitation. However, it is known 
from earlier studies that OT concentration in the blood 
of animals receiving hypertonic solution to drink rises 
significantly [6, 66]. In the present study, the third series 
of rats received a 2% solution of NaCl ad libitum for eight 
days before decapitation. This concentration of saline has 
been used in previous studies as it is known to provoke 
hypertonic overhydration [6, 65], as confirmed by the 
significant increases of plasma osmolality and haematocrit 
index values seen in salt-loaded animals in series 3. 
In the present study, the OT-ergic neurons of the 
hypothalamo-neurohypophysial system obtained from 
osmotically challenged rats responded to Gal added 
into the medium in a different way than during acute 
osmotic stimulus. Although Gal stimulated basal OT 
secretion from NH and K+-evoked OT release from the 
Hth and Hth-NH explants, it did not change basal OT 
release from the Hth and Hth-NH system. It is hard to 
comment on this significant difference between the re-
actions of OT-ergic neurons to Gal under the influence 
of either acute or chronic osmotic stimuli. However, the 
possibility that Gal receptors adapt to a prolonged state 
of osmoreceptors activation cannot be ruled out. Also, 
this present observation does not confirm earlier find-
ings that Gal injected icv into salt-loaded rats diminishes 
OT secretion from the neurohypophysis into the blood 
[6]. However, Burazin et al. [67] noted increased levels 
of Gal-R1 mRNA as well as the intensity of Gal-R1-like 
immunostaining in the SON and magnocellular PVN 
after four days of salt-loading, and propose that Gal may 
influence AVP synthesis and/or release (OT as well) via 
autocrine or paracrine activation of Gal-R1 receptors 
especially during long-lasting stimulation. 
However, it cannot be excluded that the effects of 
such regulation of neurohypophysial neurohormone 
release may be different under in vivo or in vitro condi-
tions. Moreover, the distorted Gal receptor function 
in salt-loaded rats may be the reason for the different 
responses seen when Gal is incubated with either neural 
tissue or neural fragments taken from intact animals 
(series 1 and 2). Gundlach and Burazin [68] suggest 
that a differential expression (or level of expression) of 
Gal receptor subtypes exists in different hypothalamic 
and other neuronal areas, as well as the possibility of 
a differential response of these receptors in situations 
where the amount of galanin peptide is increased.   
Papas and Bourque [69] and Depczyński et al. [70] 
postulate that the hyperpolarising properties of Gal for 
the membrane activity of magnocellular neurons restrict 
AVP and OT release from neurohypophysial axonal ter-
minals. Kozoriz et al. [71] demonstrated not only that Gal 
presynaptically reduces eEPSCs (excitatory postsynaptic 
currents) of SON magnocellular neurons (MCNs) in non 
dehydrated and dehydrated rats, but also that Gal in-
creases the postsynaptic hyperpolarisation of MCNs after 
two days of dehydration. It is possible that Gal reduces 
depolarisation of MCNs and then restricts AVP and OT 
release. Our present results related to OT release in vitro 
under the influence of Gal in different water-electrolyte 
states seem to only partially agree with these studies. 
Conclusions
Our in vitro experiments show that:
1. Gal plays the role of an inhibitory neuromodulator 
of OT release from the neurohypophysis; its effect 
is opposite at the hypothalamic level.
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2. It may be assumed that Gal acts as the stimulatory 
neuromodulator of OT release in response to pro-
longed osmotic stimulus; an acute osmotic stimulus 
blocks OT-ergic neurons susceptible to Gal.
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